GlassScriptPhysician profile
Scott Corey Jones
NPI 1629049895
$2,601.80
in general payments reported to CMS, 2019-2025
17 companies · $908 in 2025
The $908 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.91 · 2022: $36.54 · 2023: $422 · 2024: $1,223 · 2025: $908.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,553.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $649.79 | 2021-2025 | Rybelsus, Wegovy, Ozempic |
| Abbvie INC. | $439.04 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $245.27 | 2023-2025 | Airsupra, Farxiga |
| Lilly USA, LLC | $235.97 | 2023-2025 | Mounjaro, Zepbound, Trulicity |
| Glaxosmithkline, LLC. | $206.34 | 2023-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Amgen INC. | $176.08 | 2023-2025 | Evenity, Repatha, Prolia |
| Pfizer INC. | $149.89 | 2023-2025 | |
| Exact Sciences Corporation | $133.16 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $74.84 | 2022-2025 | Freestyle Libre 3 |
| Dynavax Technologies Corporation | $69.28 | 2024-2025 | Heplisav-B |
| Dexcom, INC. | $61.18 | 2023-2025 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $46.48 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $26.35 | 2024 | Rexulti |
| Merck Sharp & Dohme LLC | $26.22 | 2025 | Capvaxive, Gardasil 9 |
| Boston Scientific Corporation | $24.65 | 2024 | Watchman Access System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $18.80 | 2024 | Voquezna |
| Si-Bone, INC. | $18.46 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.